Readoutin 45d
Regeneron Pharmaceuticals — Fianlimab
Phase 3 primary completion: A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery.
- Date
- Jan 2027
- Type
- Readout
- Indication
- Melanoma